$COYA Cashflow Statement | Understand Stock

$COYA

$4.12 +$0.17 (4.3%) Close

$COYA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities:
Net loss
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation
Change in fair value of convertible promissory notes
Stock-based compensation, including the issuance of restricted stock
Debt issuance costs
Acquired in-processing research and development
Acquired in-process research and development

Changes in operating assets and liabilities:
Collaboration receivable
Prepaids and other current assets
Accounts payable
Accrued expenses
Deferred collaboration revenue
Net cash used in operating activities
Cash flows from investing activities:
Purchase of in-process research and development assets
Net cash used in investing activities
Cash flows from financing activities:
Proceed from sale of common stock from 2023 Private Placement, net of offering costs
Proceeds from sale of common stock from 2023 Private Placement, net of offering costs
Proceeds from issuance of common stock upon IPO, net of offering costs
Proceeds from sale of common stock, net of offering costs
Payment of deferred financing costs related to the IPO
Proceeds from issuance of convertible promissory notes
Payments of debt issuance costs
Payment of financing costs related to the 2023 Private Placement
Proceeds from subscription receivable
Proceeds from the exercise of stock options
Proceeds from the exercise of warrants
Net cash provided by financing activities

Net increase in cash and cash equivalents
Cash and cash equivalents as of beginning of the year
Cash and cash equivalents as of end of the year
Supplemental disclosures of non-cash financing activities:
Deferred financing costs in accounts payable and accrued expense
Conversion of convertible preferred stock upon IPO
Conversion of convertible promissory notes upon IPO
Subscription receivable related to warrant exercise
Financing costs related to the 2023 Private Placement in accrued expenses and accounts payable
Financing costs related to the 2023 Private Placement in accrued expenses
Financing costs related to the 2023 Private Placement in accounts payable
Deferred financing costs related to the IPO in accrued expenses
In process research and development costs in accrued expenses

Comments